Symbols / BCAX Stock $22.84 -3.34% Bicara Therapeutics Inc.

Healthcare • Biotechnology • United States • NGM
BCAX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 1.50B Enterprise Value 1.08B Income -137.95M Sales — Book/sh 7.37 Cash/sh 6.34
Dividend Yield — Payout — Employees 103 IPO — P/E — Forward P/E -7.52
PEG — P/S — P/B 3.10 P/C — EV/EBITDA -6.96 EV/Sales —
Quick Ratio 14.33 Current Ratio 14.58 Debt/Eq 0.43 LT Debt/Eq — EPS (ttm) -2.52 EPS next Y -3.04
EPS Growth — Revenue Growth — Earnings 2026-05-12 ROA -20.67% ROE -30.89% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 65.47M Shs Float 42.32M Short Float 21.06%
Short Ratio 15.79 Short Interest — 52W High 24.25 52W Low 7.80 Beta — Avg Volume 551.03K
Volume 464.07K Target Price $30.50 Recom None Prev Close $23.63 Price $22.84 Change -3.34%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-18.26
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest BCAX news

No recent news from Yahoo. Try the RSS feed for latest BCAX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-21 HYEP IVAN Chief Financial Officer — 9,200 $23.00 $211,614
2026-04-21 HYEP IVAN Chief Financial Officer — 9,200 $3.79 $34,866
2026-04-20 MAZUMDAR CLAIRE Chief Executive Officer — 15,000 $23.61 $354,146
2026-04-20 MAZUMDAR CLAIRE Chief Executive Officer — 37,760 $3.79 $160,206
2026-04-15 COHLHEPP RYAN President — 12,500 $23.01 $287,591
2026-04-15 COHLHEPP RYAN President — 8,000 $3.79 $30,318
2026-03-25 RABEN DAVID M.D. Officer — 5,500 $18.95 $104,229
2026-03-25 RABEN DAVID M.D. Officer — 5,500 $3.79 $20,844
2026-03-23 HYEP IVAN Chief Financial Officer — 9,200 $18.52 $170,348
2026-03-23 HYEP IVAN Chief Financial Officer — 9,200 $3.79 $34,866
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category